[Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy]. [electronic resource]
Producer: 20180531Description: 86-96 p. digitalISSN:- 0040-3660
- Adult
- Aftercare -- methods
- Dasatinib -- administration & dosage
- Disease Progression
- Female
- Humans
- Imatinib Mesylate -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Male
- Middle Aged
- Molecular Imaging -- methods
- Outcome and Process Assessment, Health Care
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Risk Assessment
- Russia
- Withholding Treatment -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.